Current best practices and rationalistic perspectives in causation-based prevention, early detection and multidisciplinary treatment of breast and gastric cancer

Gastric & Breast Cancer
DOI: 10.2122/gbc.2003.0024


Evidence-based Approach: Is it Time to Change Funding, Research Policy and Treatment Strategy of Gastric Cancer in the Western World?
Little progress has been made in the treatment of gastric cancer during the last decades in the USA. Public health efforts and research at improving survival have exclusively been focused on expensive multimodality therapies funded by industry rather than strong quality control of surgery. Currently, convincing evidence indicates the paramount importance of surgeon volume and technical skill in improving patient outcomes.
Now, a multicenter Japanese randomized controlled trial (RCT) providing fascinating findings for the ability of surgery with appropriate extensive lymph node dissection to control serosa-negative cancer, strongly questions current treatment practice in the West. .

Considering advances in understanding the patterns of recurrences after primary tumor resection and growing evidence for the ability of high-quality surgery to improve survival, should we change current treatment strategy and research policy on stage-specific inclusion of patients in multimodality perioperative therapeutics protocols?

Find Delta Dental, MetLife Dental, Aetna Dentist, New York Dentist, San Francisco Dentist, Boston Dentist, Chicago Dentist, Los Angeles Dentist & San Diego Dentist at

Online ISSN : 1109 - 7647
   Print ISSN : 1109 - 7655

We subscribe to the HONcode principles of the HON Foundation. Click to verify. We subscribe to the HONcode principles. Verify here.
please, read our policy about privacy and confidentiality of information and transparency of sponsorship

last update: 12 December 2003